Rainbow Childrens Medicare Ltd

AI

Rainbow Childrens Medicare Ltd

₹ 1,281 0.45%
11 Nov - close price
About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Key Points

Business Overview:[1]
The company operates 24 hospitals
and 5 clinics across 9 cities, with a total
bed capacity of 2,565. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."

  • Market Cap ₹ 12,991 Cr.
  • Current Price ₹ 1,281
  • High / Low ₹ 1,610 / 1,009
  • Stock P/E 51.1
  • Book Value ₹ 171
  • Dividend Yield 0.27 %
  • ROCE 16.3 %
  • ROE 14.6 %
  • Face Value ₹ 10.0

Pros

  • Company's median sales growth is 19.0% of last 10 years

Cons

  • Stock is trading at 7.47 times its book value
  • Dividend payout has been low at 13.7% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
319 322 326 315 404 382 354 335 408 394 408 411 487
204 208 223 225 260 251 243 235 268 264 279 296 336
Operating Profit 114 114 103 90 143 130 111 100 141 131 129 115 151
OPM % 36% 35% 32% 29% 36% 34% 31% 30% 34% 33% 32% 28% 31%
9 8 12 11 11 13 14 19 8 11 4 13 8
Interest 13 14 16 17 17 17 17 17 17 18 19 19 20
Depreciation 25 26 31 32 33 34 33 33 33 35 36 38 40
Profit before tax 86 83 68 52 104 92 75 69 98 88 78 71 100
Tax % 25% 26% 26% 25% 25% 27% 27% 25% 26% 26% 24% 25% 25%
64 61 50 39 77 67 55 52 73 66 59 53 75
EPS in Rs 6.30 6.02 4.97 3.82 7.62 6.60 5.37 5.09 7.20 6.48 5.84 5.19 7.39
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
148 234 402 543 695 614 925 1,114 1,237 1,455 1,546 1,700
110 204 332 430 486 449 626 729 820 976 1,042 1,174
Operating Profit 39 30 70 112 209 166 299 385 417 479 504 526
OPM % 26% 13% 17% 21% 30% 27% 32% 35% 34% 33% 33% 31%
10 16 10 8 12 12 21 27 37 49 42 35
Interest 2 3 4 6 46 44 53 55 59 74 75 76
Depreciation 7 18 28 36 65 68 77 84 105 132 136 148
Profit before tax 40 24 47 79 109 66 190 273 289 322 334 337
Tax % 33% 28% 22% 25% 35% 25% 25% 25% 26% 26% 25%
27 17 36 60 71 49 142 206 215 238 250 253
EPS in Rs 3.58 2.30 4.15 6.78 8.06 5.62 15.13 20.28 21.17 23.40 24.62 24.90
Dividend Payout % 7% 11% 12% 7% 12% 0% 13% 15% 14% 13% 14%
Compounded Sales Growth
10 Years: 21%
5 Years: 20%
3 Years: 12%
TTM: 15%
Compounded Profit Growth
10 Years: 36%
5 Years: 36%
3 Years: 4%
TTM: 3%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 8%
1 Year: -5%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 16%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 9 9 44 44 44 44 94 102 102 102 102 102
Reserves 170 272 304 359 371 421 531 987 1,184 1,387 1,588 1,638
11 24 24 61 480 495 559 538 735 734 801 866
31 40 73 91 117 109 101 127 130 131 158 181
Total Liabilities 221 346 445 555 1,012 1,070 1,285 1,753 2,150 2,354 2,648 2,787
54 123 293 333 663 722 813 891 1,219 1,368 1,458 1,554
CWIP 30 28 12 21 43 29 6 23 20 28 79 101
Investments 24 2 0 5 24 37 42 105 346 596 589 535
113 193 140 197 282 282 424 734 566 362 522 598
Total Assets 221 346 445 555 1,012 1,070 1,285 1,753 2,150 2,354 2,648 2,787

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
23 17 48 96 178 142 214 316 306 385 381
-21 -107 -42 -125 -123 -87 -169 -460 -214 -263 -241
-4 92 -7 31 -54 -56 -41 148 -97 -113 -139
Net Cash Flow -1 2 -2 2 1 -2 4 3 -4 9 0
Free Cash Flow -37 -47 -103 16 117 66 156 176 -46 242 182
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 95% 88% 88% 98% 95% 101% 92% 102% 94% 98% 95%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 11 10 14 19 19 27 16 17 21 20 24
Inventory Days 39 35 36 32 52 35 27 43 52 44 55
Days Payable 130 107 148 153 152 190 115 182 177 152 160
Cash Conversion Cycle -80 -62 -97 -102 -80 -128 -72 -123 -104 -89 -81
Working Capital Days -24 -34 -30 -5 1 5 -14 79 44 19 10
ROCE % 7% 20% 23% 12% 23% 24% 19% 18% 16%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ALOS
days

Log in to view insights

Please log in to see hidden values.

Login
Capacity Beds
count
IP Discharges
count
Occupancy
%
OP Consultations
count
ARPOB
INR per day
Deliveries
count
Operational Beds
count
Number of Hospitals
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
49.83% 49.83% 49.87% 49.85% 49.85% 49.85% 49.85% 49.85% 49.84% 49.84% 49.84% 49.83%
22.32% 24.04% 24.78% 25.12% 25.12% 23.69% 23.60% 21.85% 19.24% 17.24% 16.03% 14.66%
15.62% 14.76% 13.81% 13.84% 13.87% 15.31% 15.44% 17.46% 19.49% 21.12% 22.56% 23.28%
12.23% 11.37% 11.53% 11.20% 11.16% 11.14% 11.11% 10.82% 11.40% 11.68% 11.39% 11.84%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.12% 0.18% 0.40%
No. of Shareholders 80,47177,15278,55777,52478,76479,09280,32081,13488,80988,56189,30592,814

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

Concalls